Os Therapies INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
OSTX
Os Therapies INCShalom Auerbach and Einodmil LLC updated their beneficial ownership in OS Therapies Inc, reporting a slight reduction in Einodmil's stake through an open market sale.
AMEX
OSTX
Os Therapies INCSCHEDULE 13D/A: Key Shareholder Einodmil LLC Reduces Stake in OS Therapies Inc Through Recent Stock Sales
Einodmil LLC, a significant beneficial owner of OS Therapies Inc, has reported the sale of 142,012 shares of common stock in April and May 2025, reducing its stake to 9.8%.
AMEX
OSTX
Os Therapies INCShalom Auerbach and Einodmil LLC have filed an Amendment No. 2 to their Schedule 13D, updating their beneficial ownership in OS Therapies Inc. and clarifying past transactions following an SEC comment letter.
AMEX
OSTX
Os Therapies INCSCHEDULE 13D/A: Significant Shareholder Updates Stake in OS Therapies Inc, Increasing Beneficial Ownership to 12.9%
Shalom Auerbach and Einodmil LLC have updated their beneficial ownership in OS Therapies Inc, reflecting an increase in shares held by Einodmil LLC through an additional transfer, while also disclosing a recent sale of shares.
AMEX
OSTX
Os Therapies INCSCHEDULE 13D: Major Shareholder Discloses Significant Stake and Strategic Agreements in OS Therapies Inc.
Shalom Auerbach and Einodmil LLC have filed a Schedule 13D, revealing beneficial ownership of 11.9% and 11.8% respectively in OS Therapies Incorporated, detailing share acquisitions through note conversions and a strategic transfer agreement tied to the company's IPO.